Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.635
+0.025 (1.55%)
At close: Oct 10, 2025, 4:00 PM EDT
1.590
-0.045 (-2.75%)
After-hours: Oct 10, 2025, 7:49 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Cellular Immunotherapies
13.63M
Log In
Log In
Log In
Log In
Upgrade
Cellular Immunotherapies Growth
-78.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
United States
13.63M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-78.55%
Log In
Log In
Log In
Log In
Upgrade